ASX Today, page-33463

First 33463 Last

Share
Profile

Follow
Jeffro1990

548 Posts.

149

07/10/23

12:07

Post #: 70223026
Share

Originally posted by Scarpa: ↑

There are a few technicalities here that many are focussing on.

Yes under a SOA all the shares go to ALB should the achieve the 75% acceptance goal, but I think what most are not considering is how Gina can get a stake in ALB. There is nothing stopping ALB, were it successful in the LTR SOA, IMO to make LTR a private subsidiary company and give Gina say 20% share in that entity in return for Gina accepting the ALB bid. If there is a defacto agreement between Gina/ALB it will transcend to a JV in a private entity where the LTR assets will move to if the SOA is successful.

If you look at Greenbushes and Mount Marion they are actually a private entity where the JV partners have a common share in that private entity.

If the bid fails and ALB can keep the shares it gets in LTR, those shares plus Gina's, probably will give ALB/Gina a potential majority to control LTR, even were it to remain listed on the ASX. Or Gina could block the bid, launch her own takeover offer, and/or get into bed with MIN. I do not believe Gina will simply be after a seat on the LTR board and have no control/leadership over the direction is my point.

At the end of the day, we don't have a clue at this stage what Gina's end goal is. However, I am certain it is not about protecting shareholder interests (i.e. ours).

Is their anyone with a corporate law background on here who could clarify what scenarios might prevail here. I am guessing here but haven't a clue around this type of stuff - just trying to put a view down on what may be happening here but someone else with the right background is better placed to comment.

All IMO

Expand

Yes that is quite possible how HP may end up involved with ALB post a successful SOA.

I was only referring to the SOA itself, if it passes we are all then non-holders of LTR so it ceases to be relevant what the ownership structure of the business is.

If the SOA doesn't pass, then a hostile takeover will be needed for even a joint HP/ALB entity to hold greater than 50% of LTR.

LTR Price at posting: $2.99 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

CXU

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

There are more pages in this discussion • 10,981 more messages in this thread...

First 33463 Last

Add LTR (ASX) to my watchlist

(20min delay)
Last 65.5¢		Change 0.005(0.77%)		Mkt cap ! $1.576B

Open	High	Low	Value	Volume
65.0¢	67.5¢	65.0¢	$5.098M	7.701M

Buyers (Bids)

No.	Vol.	Price($)
43	214218	65.0¢

Sellers (Offers)

Price($)	Vol.	No.
65.5¢	154772	13

View Market Depth

No.	Vol.	Price($)
34	119403	0.650
38	510142	0.645
30	611012	0.640
8	1213710	0.635
13	164474	0.630

Price($)	Vol.	No.
0.655	341642	24
0.660	355383	16
0.665	285975	18
0.670	283473	9
0.675	476571	16

Last trade - 14.00pm 18/09/2024 (20 minute delay)

LTR (ASX) Chart

ASX Today, page-33463

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

ASX Today, page-33463

Top Stories

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News